Compare Gitcoin (GTC) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gitcoin vs Enzyme — how do they compare? Gitcoin trades at Rp1,262 (market cap Rp109,86M, Rp47,1M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is the larger of the two by market cap, and Gitcoin's circulating supply is 87,5M GTC versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Gitcoin for 23 Days and Enzyme for 28 Days on average.
| GTC | MLN | |
|---|---|---|
Market Cap | Rp109,86M | Rp134,13M |
Volume (24h) | Rp47,1M | Rp104,56M |
Circulating Supply | 87,5M GTC | 3,3M MLN |
Typical Hold Time | 23 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gitcoin (GTC) is trading at Rp1,264 with a market cap of Rp109.75 million, showing a bullish technical signal overall, supported by moving averages. The current price sits at the pivot point, with key support at Rp1,245 and resistance at Rp1,302. On-chain metrics indicate a short average hold time of 23 days, suggesting active trading. No major protocol upgrades or ecosystem developments were noted in recent crypto-specific news sources.
The outlook is cautiously optimistic due to bullish technical indicators, but limited by neutral oscillators and thin liquidity. Key opportunities include potential breakout above Rp1,302, while risks involve high volatility from low market cap and regulatory uncertainty in the crypto space. Investors should monitor trading volume and broader market sentiment.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
About Gitcoin
Gitcoin develops tools that help communities fund, build, and protect important projects. Its Gitcoin Grants Program has distributed over $54 million to early-stage builders supporting public goods in DeFi, climate, open source, and more. Key products include Gitcoin Grants Stack (a grants management platform), Allo Protocol (an open-source funding system), and Gitcoin Passport (a decentralized identity tool). GTC, Gitcoin’s governance token launched in May 2021, is used to create and fund the DAO that oversees Gitcoin.
Read more on GTC →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
